PI
IGMS

Putnam Investments’s IGM Biosciences IGMS Stock Holding History

Putnam Investments’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,474
Closed -$305K – 1195
2023
Q3 		$305K Buy
36,474
+7,298
+25% +$61.9K ﹤0.01% 1068
2023
Q2 		$269K Buy
29,176
+8,518
+41% +$95.4K ﹤0.01% 1101
2023
Q1 		$284K Buy
20,658
+5,510
+36% +$114K ﹤0.01% 1088
2022
Q4 		$258K Sell
15,148
-5,087
-25% -$102K ﹤0.01% 1090
2022
Q3 		$460K Sell
20,235
-356
-2% -$7.19K ﹤0.01% 950
2022
Q2 		$371K Buy
20,591
+8,356
+68% +$149K ﹤0.01% 1026
2022
Q1 		$327K Buy
12,235
+2,102
+21% +$39.1K ﹤0.01% 1108
2021
Q4 		$297K Buy
+10,133
New +$504K ﹤0.01% 1101

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Putnam Investments's IGMS Position: Q4 2023 in Review

Putnam Investments sold out of IGM Biosciences (IGMS) in Q4 2023, closing a stake of 36,474 shares — an estimated $305K sold.

Putnam Investments first reported a position in IGMS in Q4 2021 and held it in 8 quarters. The position peaked at $460K in Q3 2022. 72 funds tracked by Wall St. Rank hold IGMS as of Q4 2023.

  • Putnam Investments reported no remaining IGM Biosciences position as of Q4 2023 after selling out during the quarter.
  • Putnam Investments sold 36,474 IGM Biosciences shares in Q4 2023, an estimated $305K.
  • Putnam Investments first reported a position in IGM Biosciences in Q4 2021 and held it in 8 quarters.
  • Putnam Investments's IGM Biosciences position peaked at $460K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.